These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25950007)

  • 1. A novel multidisciplinary intervention for long-term weight loss and glycaemic control in obese patients with diabetes.
    Lih A; Pereira L; Bishay RH; Zang J; Omari A; Atlantis E; Kormas N
    J Diabetes Res; 2015; 2015():729567. PubMed ID: 25950007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of non-surgical weight management on weight and glycaemic control in people with type 2 diabetes: A comparison of interventional and non-interventional outcomes at 3 years.
    Botha S; Forde L; MacNaughton S; Shearer R; Lindsay R; Sattar N; Morrison D; Welsh P; Logue J
    Diabetes Obes Metab; 2018 Apr; 20(4):879-888. PubMed ID: 29178635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes disease stage predicts weight loss outcomes with long-term appetite suppressants.
    Khan MA; St Peter JV; Breen GA; Hartley GG; Vessey JT
    Obes Res; 2000 Jan; 8(1):43-8. PubMed ID: 10678258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Low-Energy Diet or Exercise on Cardiovascular Function in Working-Age Adults With Type 2 Diabetes: A Prospective, Randomized, Open-Label, Blinded End Point Trial.
    Gulsin GS; Swarbrick DJ; Athithan L; Brady EM; Henson J; Baldry E; Argyridou S; Jaicim NB; Squire G; Walters Y; Marsh AM; McAdam J; Parke KS; Biglands JD; Yates T; Khunti K; Davies MJ; McCann GP
    Diabetes Care; 2020 Jun; 43(6):1300-1310. PubMed ID: 32220917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized clinical trial.
    Tay J; Thompson CH; Luscombe-Marsh ND; Wycherley TP; Noakes M; Buckley JD; Wittert GA; Yancy WS; Brinkworth GD
    Diabetes Obes Metab; 2018 Apr; 20(4):858-871. PubMed ID: 29178536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
    J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study.
    Aucott LS; Philip S; Avenell A; Afolabi E; Sattar N; Wild S;
    BMJ Open; 2016 Jul; 6(7):e010836. PubMed ID: 27466237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antidiabetic drug therapy in overweight and obese adults with type 2 diabetes].
    de Heer J; Parhofer K
    MMW Fortschr Med; 2013 Apr; 155(7):43-6. PubMed ID: 23668175
    [No Abstract]   [Full Text] [Related]  

  • 9. Health-related quality of life in a randomised placebo-controlled trial of sibutramine in obese patients with type II diabetes.
    Kaukua JK; Pekkarinen TA; Rissanen AM
    Int J Obes Relat Metab Disord; 2004 Apr; 28(4):600-5. PubMed ID: 14770192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control study.
    Laubner K; Riedel N; Fink K; Holl RW; Welp R; Kempe HP; Lautenbach A; Schlensak M; Stengel R; Eberl T; Dederichs F; Schwacha H; Seufert J; Aberle J
    Diabetes Obes Metab; 2018 Aug; 20(8):1868-1877. PubMed ID: 29569313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charting weight four times daily as an effective behavioural approach to obesity in patients with type 2 diabetes.
    Yamada T; Kiuchi Y; Nemoto M; Yamashita S
    Diab Vasc Dis Res; 2014 Mar; 11(2):118-20. PubMed ID: 24227536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Patient-Centered Outcomes in Obese Patients With Type 2 Diabetes 3 Years After Randomization to Roux-en-Y Gastric Bypass Surgery Versus Intensive Lifestyle Management: The SLIMM-T2D Study.
    Simonson DC; Halperin F; Foster K; Vernon A; Goldfine AB
    Diabetes Care; 2018 Apr; 41(4):670-679. PubMed ID: 29432125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A primary care register for impaired glucose handling (IGH): impact on cardiometabolic profile.
    Heald AH; Knapman H; Nair S; Chambers T; Radford D; Rushton T; Anderson SG
    Prim Care Diabetes; 2012 Oct; 6(3):213-9. PubMed ID: 22560663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness of exenatide in diabetic patients waiting for bariatric surgery.
    Iglesias P; Civantos S; Vega B; Pavón I; Guijarro G; Monereo S
    Obes Surg; 2015 Mar; 25(3):575-8. PubMed ID: 25589020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of caloric restriction with and without exercise training on oxidative stress and endothelial function in obese subjects with type 2 diabetes.
    Wycherley TP; Brinkworth GD; Noakes M; Buckley JD; Clifton PM
    Diabetes Obes Metab; 2008 Nov; 10(11):1062-73. PubMed ID: 18435772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Weight loss treatment of obese type 2 diabetic patients].
    Madsbad S; Richelsen B
    Ugeskr Laeger; 2006 Jan; 168(2):175-9. PubMed ID: 16403345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin monotherapy for type 2 diabetes mellitus.
    Saenz A; Fernandez-Esteban I; Mataix A; Ausejo M; Roque M; Moher D
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002966. PubMed ID: 16034881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss.
    Rowe R; Cowx M; Poole C; McEwan P; Morgan C; Walker M
    Curr Med Res Opin; 2005 Nov; 21(11):1885-90. PubMed ID: 16307710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vagal blocking improves glycemic control and elevated blood pressure in obese subjects with type 2 diabetes mellitus.
    Shikora S; Toouli J; Herrera MF; Kulseng B; Zulewski H; Brancatisano R; Kow L; Pantoja JP; Johnsen G; Brancatisano A; Tweden KS; Knudson MB; Billington CJ
    J Obes; 2013; 2013():245683. PubMed ID: 23984050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.